Company registration number 03610861 (England and Wales)
MEDICAL ENTOMOLOGY CENTRE LIMITED
UNAUDITED FINANCIAL STATEMENTS
(A Company Limited By Guarantee)
FOR THE YEAR ENDED 31 AUGUST 2023
MEDICAL ENTOMOLOGY CENTRE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
MEDICAL ENTOMOLOGY CENTRE LIMITED
BALANCE SHEET
AS AT 31 AUGUST 2023
31 August 2023
- 1 -
2023
2022
Notes
£
£
£
£
Current assets
-
-
Creditors: amounts falling due within one year
3
(6,327)
Net current liabilities
(6,327)
Reserves
Income and expenditure account
(6,327)
Members' funds
(6,327)
The director of the company has elected not to include a copy of the income and expenditure account within the financial statements.true
For the financial year ended 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and signed by the director and authorised for issue on 16 February 2024
Mr I Burgess
Director
Company registration number 03610861 (England and Wales)
MEDICAL ENTOMOLOGY CENTRE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023
- 2 -
1
Accounting policies
Company information
Medical Entomology Centre Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is 6 Quy Court, Colliers Lane, Stow-Cum-Quy, Cambridgeshire, CB25 9AU.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transactions costs, and are measured subsequently at amortised cost using the effective interest method.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2023
2022
Number
Number
Total
1
1
3
Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
6,327
4
Members' liability
The company is a private company limited by guarantee and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £10 towards the assets of the company in the event of liquidation.
5
Related party transactions
During the year, the company operated loans with Insect Research & Development Limited, a company under common control. The amount payable to Insect Research & Development Limited at the year end was £nil (2022 - £6,327). These loans are interest free and repayable on demand.